Makani Science

Makani Science

Private
Irvine, CaliforniaHealthcare & Life Scienceshttps://www.makaniscience.com

Last Round

Grant

May 23, 2025

Est. Valuation

$1.79M

Total Funding Raised

$1.91M

Company Overview

Makani Science, Inc. is a medical technology company dedicated to transforming respiratory care through its flagship product, the Makani Respiratory Monitoring System. Originating from research at the University of California, Irvine, the company has developed a small, wireless, wearable patch sensor that provides accurate, real-time, and continuous monitoring of a patient's breathing, including respiratory rate. The technology is designed for use in various settings, from hospitals and outpatient clinics to athletic performance and home monitoring. In April 2025, the company received FDA 510(k) clearance, a key milestone enabling it to commercialize its device. Makani Science aims to improve patient health by providing better data for earlier detection of respiratory issues and creating a large database of respiratory patterns to help predict and prevent complications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Sensors, Health IoT

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Data as a Service

AI Layer

Application

Keywords

respiratory monitoringwearable respiratory monitorwearable sensormedtechcontinuous monitoringmedical deviceremote patient monitoringRPMpatient monitoringFDA 510(k) clearanceprocedural sedationdigital healthhealth IoTCOPD monitoringsleep apnea monitoringstretchable sensor

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Makani Science Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Makani Science Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantMay 23, 2025
VC RoundMay 14, 2025
CrowdfundingApr 3, 2023
AcceleratorSep 2, 2021
AcceleratorAug 6, 2019

Key People

Founding team and executive leadership

Greg Buchert

Chief Executive Officer

Executive Team

Michael Chu

Chief Technology Officer

Executive Team

Stephen Young

Chief Financial Officer

Executive Team

Makani Science Investors

Notable investors and investment history

Makani Science Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Makani Science Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Makani Science's valuation, stock price, and market status.

Firmographic Details

HeadquartersIrvine, California
Employee Range10
Year Founded2018
Last FundingMay 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.